カテゴリー： QYResearch, 世界

世界の酸性スフィンゴミエリナーゼ欠損症薬市場 2019年

【英語タイトル】Global Acid Sphingomyelinase Deficiency Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X02872）・商品コード：DATA909X02872
・発行会社（調査会社）：QYResearch
・発行日：2019年11月15日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、酸性スフィンゴミエリナーゼ欠損症薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、LJPC-0712、ML-SA1、OKL-1014、オリプダーゼアルファ、OR-0005、その他に、用途別には、病院、クリニック、その他にセグメント区分し、酸性スフィンゴミエリナーゼ欠損症薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・酸性スフィンゴミエリナーゼ欠損症薬の世界市場概要
・酸性スフィンゴミエリナーゼ欠損症薬の製造コスト構成分析
・酸性スフィンゴミエリナーゼ欠損症薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・酸性スフィンゴミエリナーゼ欠損症薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・酸性スフィンゴミエリナーゼ欠損症薬のセグメント分析（種類別）
（LJPC-0712、ML-SA1、OKL-1014、オリプダーゼアルファ、OR-0005、その他）
・酸性スフィンゴミエリナーゼ欠損症薬のセグメント分析（用途別）
（病院、クリニック、その他）
・酸性スフィンゴミエリナーゼ欠損症薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Genzyme Corporation、La Jolla Pharmaceutical Company、Merck & Co., Inc.、Okklo Life Sciences BV、Orphazyme ApS、）
・酸性スフィンゴミエリナーゼ欠損症薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Acid Sphingomyelinase Deficiency Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Acid Sphingomyelinase Deficiency Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acid Sphingomyelinase Deficiency Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Acid Sphingomyelinase Deficiency Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Acid Sphingomyelinase Deficiency Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Genzyme Corporation
La Jolla Pharmaceutical Company
Merck & Co., Inc.
Okklo Life Sciences BV
Orphazyme ApS
…

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
LJPC-0712
ML-SA1
OKL-1014
Olipudase Alfa
OR-0005
Others

Segment by Application
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Acid Sphingomyelinase Deficiency Drug
1.1 Definition of Acid Sphingomyelinase Deficiency Drug
1.2 Acid Sphingomyelinase Deficiency Drug Segment by Type
1.2.1 Global Acid Sphingomyelinase Deficiency Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 LJPC-0712
1.2.3 ML-SA1
1.2.4 OKL-1014
1.2.5 Olipudase Alfa
1.2.6 OR-0005
1.2.7 Others
1.3 Acid Sphingomyelinase Deficiency Drug Segment by Applications
1.3.1 Global Acid Sphingomyelinase Deficiency Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Acid Sphingomyelinase Deficiency Drug Overall Market
1.4.1 Global Acid Sphingomyelinase Deficiency Drug Revenue (2014-2025)
1.4.2 Global Acid Sphingomyelinase Deficiency Drug Production (2014-2025)
1.4.3 North America Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)
1.4.4 Europe Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)
1.4.5 China Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)
1.4.6 Japan Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)
1.4.8 India Acid Sphingomyelinase Deficiency Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Acid Sphingomyelinase Deficiency Drug
2.3 Manufacturing Process Analysis of Acid Sphingomyelinase Deficiency Drug
2.4 Industry Chain Structure of Acid Sphingomyelinase Deficiency Drug

3 Development and Manufacturing Plants Analysis of Acid Sphingomyelinase Deficiency Drug
3.1 Capacity and Commercial Production Date
3.2 Global Acid Sphingomyelinase Deficiency Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Acid Sphingomyelinase Deficiency Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Acid Sphingomyelinase Deficiency Drug Production and Capacity Analysis
4.2 Acid Sphingomyelinase Deficiency Drug Revenue Analysis
4.3 Acid Sphingomyelinase Deficiency Drug Price Analysis
4.4 Market Concentration Degree

5 Acid Sphingomyelinase Deficiency Drug Regional Market Analysis
5.1 Acid Sphingomyelinase Deficiency Drug Production by Regions
5.1.1 Global Acid Sphingomyelinase Deficiency Drug Production by Regions
5.1.2 Global Acid Sphingomyelinase Deficiency Drug Revenue by Regions
5.2 Acid Sphingomyelinase Deficiency Drug Consumption by Regions
5.3 North America Acid Sphingomyelinase Deficiency Drug Market Analysis
5.3.1 North America Acid Sphingomyelinase Deficiency Drug Production
5.3.2 North America Acid Sphingomyelinase Deficiency Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Acid Sphingomyelinase Deficiency Drug Import and Export
5.4 Europe Acid Sphingomyelinase Deficiency Drug Market Analysis
5.4.1 Europe Acid Sphingomyelinase Deficiency Drug Production
5.4.2 Europe Acid Sphingomyelinase Deficiency Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Acid Sphingomyelinase Deficiency Drug Import and Export
5.5 China Acid Sphingomyelinase Deficiency Drug Market Analysis
5.5.1 China Acid Sphingomyelinase Deficiency Drug Production
5.5.2 China Acid Sphingomyelinase Deficiency Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Acid Sphingomyelinase Deficiency Drug Import and Export
5.6 Japan Acid Sphingomyelinase Deficiency Drug Market Analysis
5.6.1 Japan Acid Sphingomyelinase Deficiency Drug Production
5.6.2 Japan Acid Sphingomyelinase Deficiency Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Acid Sphingomyelinase Deficiency Drug Import and Export
5.7 Southeast Asia Acid Sphingomyelinase Deficiency Drug Market Analysis
5.7.1 Southeast Asia Acid Sphingomyelinase Deficiency Drug Production
5.7.2 Southeast Asia Acid Sphingomyelinase Deficiency Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Acid Sphingomyelinase Deficiency Drug Import and Export
5.8 India Acid Sphingomyelinase Deficiency Drug Market Analysis
5.8.1 India Acid Sphingomyelinase Deficiency Drug Production
5.8.2 India Acid Sphingomyelinase Deficiency Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Acid Sphingomyelinase Deficiency Drug Import and Export

6 Acid Sphingomyelinase Deficiency Drug Segment Market Analysis (by Type)
6.1 Global Acid Sphingomyelinase Deficiency Drug Production by Type
6.2 Global Acid Sphingomyelinase Deficiency Drug Revenue by Type
6.3 Acid Sphingomyelinase Deficiency Drug Price by Type

7 Acid Sphingomyelinase Deficiency Drug Segment Market Analysis (by Application)
7.1 Global Acid Sphingomyelinase Deficiency Drug Consumption by Application
7.2 Global Acid Sphingomyelinase Deficiency Drug Consumption Market Share by Application (2014-2019)

8 Acid Sphingomyelinase Deficiency Drug Major Manufacturers Analysis
8.1 Genzyme Corporation
8.1.1 Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
8.1.2 Genzyme Corporation Product Introduction, Application and Specification
8.1.3 Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 La Jolla Pharmaceutical Company
8.2.1 La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
8.2.2 La Jolla Pharmaceutical Company Product Introduction, Application and Specification
8.2.3 La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Merck & Co., Inc.
8.3.1 Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
8.3.2 Merck & Co., Inc. Product Introduction, Application and Specification
8.3.3 Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Okklo Life Sciences BV
8.4.1 Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
8.4.2 Okklo Life Sciences BV Product Introduction, Application and Specification
8.4.3 Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Orphazyme ApS
8.5.1 Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
8.5.2 Orphazyme ApS Product Introduction, Application and Specification
8.5.3 Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served

9 Development Trend of Analysis of Acid Sphingomyelinase Deficiency Drug Market
9.1 Global Acid Sphingomyelinase Deficiency Drug Market Trend Analysis
9.1.1 Global Acid Sphingomyelinase Deficiency Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Acid Sphingomyelinase Deficiency Drug Regional Market Trend
9.2.1 North America Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.2.2 Europe Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.2.3 China Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.2.4 Japan Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.2.5 Southeast Asia Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.2.6 India Acid Sphingomyelinase Deficiency Drug Forecast 2019-2025
9.3 Acid Sphingomyelinase Deficiency Drug Market Trend (Product Type)
9.4 Acid Sphingomyelinase Deficiency Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Acid Sphingomyelinase Deficiency Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Acid Sphingomyelinase Deficiency Drug
Table Global Acid Sphingomyelinase Deficiency Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Acid Sphingomyelinase Deficiency Drug Production Market Share by Types in 2018
Figure LJPC-0712 Product Picture
Figure ML-SA1 Product Picture
Figure OKL-1014 Product Picture
Figure Olipudase Alfa Product Picture
Figure OR-0005 Product Picture
Figure Others Product Picture
Table Global Acid Sphingomyelinase Deficiency Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Acid Sphingomyelinase Deficiency Drug Consumption Market Share by Applications in 2018
Figure Hospital
Figure Clinic
Figure Others
Figure Global Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) (2014-2025)
Figure Global Acid Sphingomyelinase Deficiency Drug Production (K Pcs) (2014-2025)
Figure North America Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Figure Europe Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Figure China Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Figure Japan Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Figure India Acid Sphingomyelinase Deficiency Drug Market Size (Million USD) (2014-2025)
Table Acid Sphingomyelinase Deficiency Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Acid Sphingomyelinase Deficiency Drug in 2018
Figure Manufacturing Process Analysis of Acid Sphingomyelinase Deficiency Drug
Figure Industry Chain Structure of Acid Sphingomyelinase Deficiency Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Acid Sphingomyelinase Deficiency Drug Manufacturing Plants Distribution
Table Acid Sphingomyelinase Deficiency Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Acid Sphingomyelinase Deficiency Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Acid Sphingomyelinase Deficiency Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Acid Sphingomyelinase Deficiency Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Acid Sphingomyelinase Deficiency Drug Production Share by Manufacturers in 2018
Table Acid Sphingomyelinase Deficiency Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Acid Sphingomyelinase Deficiency Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Acid Sphingomyelinase Deficiency Drug Revenue Share by Manufacturers in 2018
Table Acid Sphingomyelinase Deficiency Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Acid Sphingomyelinase Deficiency Drug Production by Regions 2014-2019 (K Pcs)
Table Global Acid Sphingomyelinase Deficiency Drug Production Market Share by Regions 2014-2019
Figure Global Acid Sphingomyelinase Deficiency Drug Production Market Share by Regions in 2018
Table Global Acid Sphingomyelinase Deficiency Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Acid Sphingomyelinase Deficiency Drug Revenue Market Share by Regions 2014-2019
Figure Global Acid Sphingomyelinase Deficiency Drug Revenue Market Share by Regions in 2018
Table Global Acid Sphingomyelinase Deficiency Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Acid Sphingomyelinase Deficiency Drug Consumption Market Share by Regions 2014-2019
Figure North America Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure China Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure India Acid Sphingomyelinase Deficiency Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Acid Sphingomyelinase Deficiency Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Acid Sphingomyelinase Deficiency Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Acid Sphingomyelinase Deficiency Drug Market Share by Application (2014-2019)
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Product Introduction, Application and Specification
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production Growth Rate (2014-2019)
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Production Market Share (2014-2019)
Figure Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Revenue Market Share (2014-2019)
Table Genzyme Corporation Acid Sphingomyelinase Deficiency Drug Main Business and Markets Served
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Product Introduction, Application and Specification
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production Growth Rate (2014-2019)
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Production Market Share (2014-2019)
Figure La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Revenue Market Share (2014-2019)
Table La Jolla Pharmaceutical Company Acid Sphingomyelinase Deficiency Drug Main Business and Markets Served
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Product Introduction, Application and Specification
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production Growth Rate (2014-2019)
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Production Market Share (2014-2019)
Figure Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Revenue Market Share (2014-2019)
Table Merck & Co., Inc. Acid Sphingomyelinase Deficiency Drug Main Business and Markets Served
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Product Introduction, Application and Specification
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production Growth Rate (2014-2019)
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Production Market Share (2014-2019)
Figure Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Revenue Market Share (2014-2019)
Table Okklo Life Sciences BV Acid Sphingomyelinase Deficiency Drug Main Business and Markets Served
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production Sites and Area Served
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Product Introduction, Application and Specification
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production Growth Rate (2014-2019)
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Production Market Share (2014-2019)
Figure Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Revenue Market Share (2014-2019)
Table Orphazyme ApS Acid Sphingomyelinase Deficiency Drug Main Business and Markets Served
Figure Global Acid Sphingomyelinase Deficiency Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Acid Sphingomyelinase Deficiency Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Acid Sphingomyelinase Deficiency Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Acid Sphingomyelinase Deficiency Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Acid Sphingomyelinase Deficiency Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Acid Sphingomyelinase Deficiency Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Acid Sphingomyelinase Deficiency Drug by Application (2019-2025)
Table Acid Sphingomyelinase Deficiency Drug Distributors List
Table Acid Sphingomyelinase Deficiency Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Genzyme Corporation、La Jolla Pharmaceutical Company、Merck & Co., Inc.、Okklo Life Sciences BV、Orphazyme ApS、

★調査レポート[世界の酸性スフィンゴミエリナーゼ欠損症薬市場 2019年] (コード：DATA909X02872)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の酸性スフィンゴミエリナーゼ欠損症薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • α1-アンチトリプシン(AAT)欠乏症増強療法の世界市場：規模・現状・予測2019-2025
    DATA909X18150 / QYResearch / 2019年11月25日 / ※当調査レポートでは、α1-アンチトリプシン(AAT)欠乏症増強療法の世界市場について調査・分析し、α1-アンチトリプシン(AAT)欠乏症増強療法の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（グラッシア、アララストNP、プロラスチンC、その他）、用途別（病院、専門クリニック）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界のα1-アンチトリプシン(AAT)欠乏症増強療法市場動向 ・主要企業別マーケットシェア ・α1-アンチトリプシン(AAT)欠乏症増強療法の種類別市場規模2014-2019 （グラッシア、アララストNP、プロラスチンC、その他） ・α1-アンチトリプシン(AAT)欠乏症増強療法の用途別市場規模2014-2019 （病院、専門クリニック） ・α1-アンチトリプシン(AAT)欠乏症増強療法の北米市場：主要企業・種類別/用途別市場規模 ・α1-アンチトリプシン(AAT)欠乏症増強療法のヨーロッパ市場：主要企業・種類別/用途別市場規模...Alpha-1 antitrypsin deficiency (AATD) is an inherited condition characterized as a low or unpredictable level of alpha-1 protein, generated by liver. The disease most commonly affects lungs and liver and is often undiagnosed. Augmentation therapy is the most specific therapy for the treatment of AATD, and includes various preparations derived from pooled human plasma.In 2018, the global Alpha-1 Antitrypsin Deficiency Augmentation Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Alpha-1 Antitrypsin Deficiency Augmentation Therapy...
  • 世界のエチドロン酸市場 2019年
    DATA909X07468 / QYResearch / 2019年11月15日 / ※本調査レポートは、エチドロン酸の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、医薬品グレードエチドロン酸、工業用グレードエチドロン酸に、用途別には、製薬産業、染色産業、化粧品産業、化学産業、その他にセグメント区分し、エチドロン酸の世界市場を分析しました。 ・エグゼクティブ・サマリー ・エチドロン酸の世界市場概要 ・エチドロン酸の製造コスト構成分析 ・エチドロン酸の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・エチドロン酸の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・エチドロン酸のセグメント分析（種類別） （医薬品グレードエチドロン酸、工業用グレードエチドロン酸）...The global Etidronic Acid market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Etidronic Acid volume and value at global level, regional level and company level. From a global perspective, this report represents overall Etidronic Acid market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Etidronic Acid in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Etidronic Acid manufacturing...
  • 世界のタミフル（オセルタミビル）薬市場 2019年
    DATA909X16262 / QYResearch / 2019年11月22日 / ※本調査レポートは、タミフル（オセルタミビル）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、カプセル、経口液に、用途別には、インフルエンザA、インフルエンザBにセグメント区分し、タミフル（オセルタミビル）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・タミフル（オセルタミビル）薬の世界市場概要 ・タミフル（オセルタミビル）薬の製造コスト構成分析 ・タミフル（オセルタミビル）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・タミフル（オセルタミビル）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・タミフル（オセルタミビル）薬のセグメント分析（種類別） （カプセル、経口液）...The global Tamiflu (Oseltamivir) Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Tamiflu (Oseltamivir) Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tamiflu (Oseltamivir) Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Tamiflu (Oseltamivir) Drug in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...

    • ◆H&Iグローバルリサーチのお客様（例）◆